Jagadeesh Bayry: Molecular and Genetic Mechanisms of VITT
Jagadeesh Bayry, Professor and Head of Department at the Indian Institute of Technology Palakkad, shared a post on LinkedIn and about a recent article he and his colleagues co-authored, adding:
“An editorial commentary in Nature Reviews Cardiology, Nature Portfolio, co-authored with Julie Rayes, discusses the mechanisms underlying Vaccine-induced immune thrombotic thrombocytopenia, a rare complication of adenoviral vector-based COVID-19 vaccines.
An elegant study by the groups of J. J. Wang and Andreas Greinacher demonstrates that VITT arises from molecular mimicry between platelet factor 4 PF4 and adenoviral core protein VII.
In genetically predisposed individuals carrying IGLV3-21 star 02 or star 03 alleles, a key somatic mutation K31E in the IgG light chain redirects antiviral immunity toward pathogenic anti PF4 responses, triggering platelet activation and thrombosis.
This work provides a compelling example of how genetic background and somatic hypermutation converge to drive autoimmunity, and opens new avenues for designing safer adenoviral vector platforms.”
Title: Solving the mystery of vaccine-induced immune thrombocytopenia and thrombosis
Authors: Julie Rayes, Jagadeesh Bayry
Read the Full Article on Nature Reviews Cardiology.
Title: Adenoviral Inciting Antigen and Somatic Hypermutation in VITT
Authors: Jing Jing Wang, Linda Schönborn, Theodore E. Warkentin, Luisa Müller, Thomas Thiele, Lena Ulm, Uwe Völker, Sabine Ameling, Sören Franzenburg, Lars Kaderali, Ana Tzvetkova, Alex Colella, Tim Chataway, Chee Wee Tan, Bridie Armour, Alexander Troelnikov, Lucy Rutten, James McCluskey, Roland Zahn, Tom P. Gordon, Andreas Greinacher
Read the Full Article on The New England Journal Of Medicine.
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 24, 2026, 16:40William Wallace: Vitamin C and Collagen Work as One Biological System
-
Jun 24, 2026, 16:32Arlindo Nascimento de Lemos Junior: Thrombus Echogenicity as a Predictor of Post-Thrombotic Syndrome Severity After DVT
-
Jun 24, 2026, 16:09Jimi Olaghere: The Future of Sickle Cell Disease Research Starts With Collaboration
-
Jun 24, 2026, 16:03Von Willebrand Disease as a Common Yet Under-Recognised Bleeding Disorder – EHC
-
Jun 24, 2026, 15:57Maia Meier: Women with Bleeding Disorders Reach the Summit of Mont Blanc
-
Jun 24, 2026, 15:40Annette Bowyer: The Emerging Role of Extravascular Factor VII in Haemostasis
-
Jun 24, 2026, 13:50Tijjani Balas: Why Early Detection of DVT Matters
-
Jun 24, 2026, 13:43Brandon Michael Henry: Interpreting Complement Activation After AAV Gene Therapy
-
Jun 24, 2026, 13:37Heba Youssef: Heparin-Induced Thrombocytopenia – The Prothrombotic Emergency You Cannot Miss